Richard D Waite
Overview
Explore the profile of Richard D Waite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waite R, Stewart J, Stephen A, Allaker R
Int J Antimicrob Agents
. 2018 Apr;
52(3):338-343.
PMID: 29665443
Wound bioburden plays an important role in impaired healing and development of infection-related complications. The objective of this study was to determine the efficacy of an innovative two-layer nitric oxide-generating...
2.
Waite R, Qureshi M, Whiley R
PLoS One
. 2017 Apr;
12(4):e0176577.
PMID: 28426833
[This corrects the article DOI: 10.1371/journal.pone.0173741.].
3.
Waite R, Qureshi M, Whiley R
PLoS One
. 2017 Mar;
12(3):e0173741.
PMID: 28301571
Cystic fibrosis (CF) airways harbour complex and dynamic polymicrobial communities that include many oral bacteria. Despite increased knowledge of CF airway microbiomes the interaction between established CF pathogens and other...
4.
Martinez-Guitian M, Vazquez-Ucha J, Odingo J, Parish T, Poza M, Waite R, et al.
Antimicrob Agents Chemother
. 2016 May;
60(7):4375-9.
PMID: 27139471
Synergy between colistin and the signal peptidase inhibitor MD3 was tested against isogenic mutants and clinical pairs of Acinetobacter baumannii isolates. Checkerboard assays and growth curves showed synergy against both...
5.
Whiley R, Fleming E, Makhija R, Waite R
PLoS One
. 2015 Feb;
10(2):e0115513.
PMID: 25710466
Cystic fibrosis (CF) patient airways harbour diverse microbial consortia that, in addition to the recognized principal pathogen Pseudomonas aeruginosa, include other bacteria commonly regarded as commensals. The latter include the...
6.
Personne Y, Curtis M, Wareham D, Waite R
J Antimicrob Chemother
. 2014 Aug;
69(12):3236-43.
PMID: 25134721
Objectives: Effective treatment of Gram-negative bacterial infections is increasingly challenging due to the spread of multidrug-resistant strains and a lack of new antimicrobials in development. Bacterial type I signal peptidases...
7.
Whiley R, Sheikh N, Mushtaq N, Hagi-Pavli E, Personne Y, Javaid D, et al.
J Infect Dis
. 2013 Oct;
209(5):769-80.
PMID: 24158959
Background: The Pseudomonas aeruginosa Liverpool epidemic strain (LES) is an important cystic fibrosis (CF) pathogen and is associated with increased morbidity and a worsened prognosis, compared with other CF-associated strains....
8.
Tomoyasu T, Imaki H, Masuda S, Okamoto A, Kim H, Waite R, et al.
Infect Immun
. 2013 Jun;
81(9):3276-86.
PMID: 23798532
Streptococcus intermedius secretes a human-specific cytolysin, intermedilysin (ILY), which is considered to be the major virulence factor of this pathogen. We screened for a repressor of ily expression by using...
9.
Patell S, Gu M, Davenport P, Givskov M, Waite R, Welch M
Environ Microbiol Rep
. 2013 Jun;
2(3):440-8.
PMID: 23766118
Pseudomonas aeruginosa is a model organism for the study of intercellular communication and biofilm formation. As such, P. aeruginosa has been the subject of several microarray analyses comparing gene expression...
10.
Waite R, Rose R, Rangarajan M, Aduse-Opoku J, Hashim A, Curtis M
J Bacteriol
. 2012 Jun;
194(17):4521-36.
PMID: 22730125
Type I signal peptidases (SPases) cleave signal peptides from proteins during translocation across biological membranes and hence play a vital role in cellular physiology. SPase activity is also of fundamental...